Share
Commentary

If You Skip the Vaccine, Study Says This Drug Could Save You from Some of the Worst COVID Outcomes

Share

If you ask the Democrats, anyone who isn’t vaccinated against COVID-19 will die from the disease. No ifs or buts about it: no vaccine, you’re dead.

I’ve made no secret of the fact that I support the COVID-19 vaccines.

There is, of course, nothing wrong with the decision not to get vaccinated, and I don’t begrudge anyone who makes that decision.

America is about choice, and choice means accepting risks. As Thomas Jefferson once wrote, in Latin, to James Madison: “I prefer dangerous freedom over peaceful slavery.”

Fortunately, it seems as if unvaccinated Americans will be taking less of a risk going forward.

Trending:
Unopposed SCOTUS Decision Delivers Devastating News to BLM - Police Will Rejoice

Remdesivir, an anti-viral drug originally designed to treat Hepatitis C, was the first drug approved by the Food and Drug Administration to battle COVID-19.

Even then, initial reports seemed to indicate the drug was only marginally beneficial.

Now, Remdesivir — which is injected — appears to be more effective than anyone believed.

According to the Daily Mail, a new study has found that, when administered early, Remdesivir reduces the risk of being hospitalized with COVID-19 by 87%, and the risk of needing any formal medical visit declined by 81%.

Will these medications help end the pandemic?

“Antiviral medications provide maximal benefit when used early in the disease course,” Dr. Robert L. Gottlieb, cardiologist and principal investigator at Baylor University Medical Center and Baylor Scott & White Research Institute, said in a statement on Sept. 22. “Last summer, data from clinical trials demonstrated the benefit of remdesivir in patients hospitalized with COVID-19, even when not yet requiring oxygen.

“These latest data show remdesivir’s potential to help high-risk patients recover before they get sicker and stay out of the hospital altogether.

“We are seeing very high numbers of hospitalized patients as new COVID-19 infections surge, placing increased demands on already over-burdened healthcare systems. Remdesivir, also known as Veklury, is an effective antiviral for the treatment of hospitalized patients with COVID-19 and an essential tool to help reduce disease progression,” Gottlieb added.

Remdesivir isn’t the only drug showing promise. Molnupiravir, which comes in the form of a pill rather than an injection, is showing potential as well.

Related:
Veteran Newscaster Says She Was Fired After COVID Vax Mandate, Posts the Jaw-Dropping Rules She Was Required to Follow

All in all, “the science” never should have tried to convince people that there was only one way out of the pandemic. Vaccines are a big one, but they are only one piece of the puzzle.

Hopefully, these new drugs will ensure that people who wish to remain unvaccinated can do so safely — and give wannabe authoritarians one less mechanism to pursue power.

Truth and Accuracy

Submit a Correction →



loading

We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

Tags:
, , , , , , ,
Share
Garion Frankel is the senior policy advisor for the Texas Federation of College Republicans. He enjoys and has published articles and academic works on public policy, philosophy and political theory.
Garion Frankel is the senior policy advisor for the Texas Federation of College Republicans. He enjoys and has published articles and academic works on public policy, philosophy and political theory.
Languages Spoken
English, some Spanish




loading

Conversation